SCHEMBL1634243

SCHEMBL1634243

CC(C)N1CCC(Oc2cc(Br)cc3cnc(Nc4ccc(F)cc4)nc23)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 2/20 0.42
JAK1 P23458 2/20 0.42
TYK2 P29597 2/20 0.42
JAK3 P52333 2/20 0.42
TNIK Q9UKE5 1/20 0.40
CDK4 P11802 9/20 0.39
CCND1 P24385 9/20 0.39
CCNE1 P24864 6/20 0.39
CDK2 P24941 6/20 0.39
CDK1 P06493 5/20 0.39
CCNB1 P14635 5/20 0.39
SCN8A Q9UQD0 1/20 0.38
SLC5A7 Q9GZV3 1/20 0.36
EGFR P00533 3/20 0.36
SGK1 O00141 1/20 0.36
CHEK1 O14757 1/20 0.35
MAPK8 P45983 1/20 0.35
MAPK9 P45984 1/20 0.35
MAPK10 P53779 1/20 0.35
MAPK14 Q16539 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13498305 0.89 JAK2 (0.42) JAK2JAK1TYK2JAK3TNIK
SCHEMBL1633346 0.88 CDK2 (0.43) JAK2JAK1TYK2JAK3CDK4
SCHEMBL1633043 0.87 JAK2 (0.55) JAK2JAK1TYK2JAK3TNIK
SCHEMBL1633185 0.81 JAK2 (0.54) JAK2JAK1TYK2JAK3TNIK
SCHEMBL1634396 0.80 JAK2 (0.53) JAK2JAK1TYK2JAK3TNIK
SCHEMBL1634796 0.80 HRH3 (0.39) SLC5A7
SCHEMBL14258160 0.79 HRH3 (0.38) SLC5A7
SCHEMBL12725653 0.79 HRH3 (0.39) SLC5A7
SCHEMBL1634187 0.79 JAK2 (0.57) JAK2JAK1TYK2JAK3TNIK
SCHEMBL1632568 0.78 HRH3 (0.43) CDK4CCND1MAPK8MAPK9MAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed